Cohen Klingenstein LLC Bausch Health Companies Inc. Transaction History

Cohen Klingenstein LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 14, 2022	SELL	$23.0 - $29.01 $27,922 - $35,218	-1,214 Reduced 8.8%	12,589 $348,000
Q3 2021 Oct 15, 2021	SELL	$25.04 - $30.06 $49,679 - $59,639	-1,984 Reduced 12.57%	13,803 $384,000
Q4 2020 Jan 19, 2021	SELL	$15.31 - $21.12 $14,559 - $20,085	-951 Reduced 5.68%	15,787 $328,000
Q3 2018 Oct 15, 2018	BUY	$20.64 - $25.67 $345,472 - $429,664	16,738 New	16,738 $430,000

273

252M

5.12M

9.43M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $1.57B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Cohen Klingenstein LLC, based on Form 13F filings with the SEC.

Stay updated on Cohen Klingenstein LLC with notifications on news.